Concord Biotech informs about earnings call

06 Nov 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, Concord Biotech has informed that the Company has arranged Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September, 2024, scheduled on Tuesday, 12th November, 2024 at 03:30 pm IST. The conference/Earning Call Invitation is enclosed.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

2127.50 -1.90 (-0.09%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.